UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 725

Sortiert nach

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy?

Clinical cancer research, 2014-01, Vol.20 (2), p.310-322

2014

Link zum Volltext

Verfügbarkeit prüfen

Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12), p.2298-2312

2022

Link zum Volltext

Verfügbarkeit prüfen

Sensitisation of cancer cells to radiotherapy by serine and glycine starvation

British journal of cancer, 2022-11, Vol.127 (10), p.1773-1786

2022

Link zum Volltext

Verfügbarkeit prüfen

A rectal cancer organoid platform to study individual responses to chemoradiation

Nature medicine, 2019-10, Vol.25 (10), p.1607-1614

2019

Link zum Volltext

Verfügbarkeit prüfen

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

The lancet oncology, 2010-11, Vol.11 (11), p.1029-1035

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta‐analysis of studies over the last ten years

British journal of haematology, 2020-05, Vol.189 (3), p.452-468

2020

Link zum Volltext

Verfügbarkeit prüfen

PAF promotes stemness and radioresistance of glioma stem cells

Proceedings of the National Academy of Sciences - PNAS, 2017-10, Vol.114 (43), p.E9086-E9095

2017

Link zum Volltext

Verfügbarkeit prüfen

The Lotus Flower: Black students learning and loving through the anti‐Black labyrinth of higher ed

The Canadian review of sociology, 2021-08, Vol.58 (3), p.443-446

2021

Link zum Volltext

Verfügbarkeit prüfen

A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients

Cells (Basel, Switzerland), 2021-08, Vol.10 (9), p.2211

2021

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation

Cancers, 2023-08, Vol.15 (16), p.4161

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Clinical cancer research, 2019-11, Vol.25 (22), p.6606-6613

2019

Link zum Volltext

Verfügbarkeit prüfen

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

Cancer, 2017-05, Vol.123 (10), p.1791-1799

2017

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients

British journal of haematology, 2024-04, Vol.204 (4), p.1536-1539

2024

Link zum Volltext

Verfügbarkeit prüfen

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

Blood, 2008-10, Vol.112 (8), p.3099-3106

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 725

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(635)
Mit Volltextzugriff
(693)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(351)
Life Sciences & Biomedicine
(291)
Humans
(229)
Life Sciences
(170)
Male
(146)
Female
(135)
Middle Aged
(115)
Aged
(88)
Adult
(81)
Hematology
(63)
Oncology
(61)
Treatment Outcome
(49)
Biological And Medical Sciences
(48)
Cancer
(46)
Human Health And Pathology
(44)
Aged, 80 And Over
(43)
Medical Sciences
(41)
Patients
(39)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(38)
Young Adult
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy

Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy?

Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Sensitisation of cancer cells to radiotherapy by serine and glycine starvation

A rectal cancer organoid platform to study individual responses to chemoradiation

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta‐analysis of studies over the last ten years

PAF promotes stemness and radioresistance of glioma stem cells

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

The Lotus Flower: Black students learning and loving through the anti‐Black labyrinth of higher ed

A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients

A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients

Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

Suchergebnisse filtern